These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25994230)

  • 1. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs.
    Jha P; Agrawal R; Pathak P; Kumar A; Purkait S; Mallik S; Suri V; Chand Sharma M; Gupta D; Suri A; Sharma BS; Julka PK; Kulshreshtha R; Sarkar C
    Int J Cancer; 2015 Nov; 137(10):2343-53. PubMed ID: 25994230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter-based identification of novel non-coding RNAs reveals the presence of dicistronic snoRNA-miRNA genes in Arabidopsis thaliana.
    Qu G; Kruszka K; Plewka P; Yang SY; Chiou TJ; Jarmolowski A; Szweykowska-Kulinska Z; Echeverria M; Karlowski WM
    BMC Genomics; 2015 Nov; 16():1009. PubMed ID: 26607788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput microRNA profiling of pediatric high-grade gliomas.
    Miele E; Buttarelli FR; Arcella A; Begalli F; Garg N; Silvano M; Po A; Baldi C; Carissimo G; Antonelli M; Spinelli GP; Capalbo C; Donofrio V; Morra I; Nozza P; Gulino A; Giangaspero F; Ferretti E
    Neuro Oncol; 2014 Jan; 16(2):228-40. PubMed ID: 24305714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the miR-126 gene associated with glioma progression.
    Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
    Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
    Fontebasso AM; Schwartzentruber J; Khuong-Quang DA; Liu XY; Sturm D; Korshunov A; Jones DT; Witt H; Kool M; Albrecht S; Fleming A; Hadjadj D; Busche S; Lepage P; Montpetit A; Staffa A; Gerges N; Zakrzewska M; Zakrzewski K; Liberski PP; Hauser P; Garami M; Klekner A; Bognar L; Zadeh G; Faury D; Pfister SM; Jabado N; Majewski J
    Acta Neuropathol; 2013 May; 125(5):659-69. PubMed ID: 23417712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas.
    Paugh BS; Zhu X; Qu C; Endersby R; Diaz AK; Zhang J; Bax DA; Carvalho D; Reis RM; Onar-Thomas A; Broniscer A; Wetmore C; Zhang J; Jones C; Ellison DW; Baker SJ
    Cancer Res; 2013 Oct; 73(20):6219-29. PubMed ID: 23970477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A K27M mutations in thalamic gliomas from young adult patients.
    Aihara K; Mukasa A; Gotoh K; Saito K; Nagae G; Tsuji S; Tatsuno K; Yamamoto S; Takayanagi S; Narita Y; Shibui S; Aburatani H; Saito N
    Neuro Oncol; 2014 Jan; 16(1):140-6. PubMed ID: 24285547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.
    Jha P; Pia Patric IR; Shukla S; Pathak P; Pal J; Sharma V; Thinagararanjan S; Santosh V; Suri V; Sharma MC; Arivazhagan A; Suri A; Gupta D; Somasundaram K; Sarkar C
    Neuro Oncol; 2014 Dec; 16(12):1607-17. PubMed ID: 24997139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3 G34-mutant high-grade glioma.
    Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH
    Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.
    Gielen GH; Gessi M; Hammes J; Kramm CM; Waha A; Pietsch T
    Am J Clin Pathol; 2013 Mar; 139(3):345-9. PubMed ID: 23429371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
    Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
    Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human miRNA precursors with box H/ACA snoRNA features.
    Scott MS; Avolio F; Ono M; Lamond AI; Barton GJ
    PLoS Comput Biol; 2009 Sep; 5(9):e1000507. PubMed ID: 19763159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
    Mangerel J; Price A; Castelo-Branco P; Brzezinski J; Buczkowicz P; Rakopoulos P; Merino D; Baskin B; Wasserman J; Mistry M; Barszczyk M; Picard D; Mack S; Remke M; Starkman H; Elizabeth C; Zhang C; Alon N; Lees J; Andrulis IL; Wunder JS; Jabado N; Johnston DL; Rutka JT; Dirks PB; Bouffet E; Taylor MD; Huang A; Malkin D; Hawkins C; Tabori U
    Acta Neuropathol; 2014 Dec; 128(6):853-62. PubMed ID: 25315281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
    Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
    Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
    [No Abstract]   [Full Text] [Related]  

  • 20. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
    Dong L; Li Y; Han C; Wang X; She L; Zhang H
    Int J Oncol; 2014 Aug; 45(2):746-56. PubMed ID: 24858071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.